كتالوج المنتجات [{"id":"463","name":"Evaluation of Parsaclisib plus Bendamustine and Rituximab in patients with Newly Diagnosed Mantle Cell Lymphoma","price":1,"sku":"lymphoma-trial-2","brand":false,"position":1,"category":"Medicines\/| Clinical Trials"},{"id":"462","name":"Evaluation of Tafasitamab plus Rituximab and Lenalidomide in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-3","brand":false,"position":2,"category":"Medicines\/| Clinical Trials"},{"id":"461","name":"Evaluation of Parsaclisib plus Rituximab or Obinutuzumab in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-4","brand":false,"position":3,"category":"Medicines\/| Clinical Trials"},{"id":"460","name":"Evaluation of Tafasitamab plus Parsaclisib in patients with Non Hodgkin Lymphoma or Chronic Lymphocytic Leukemia","price":1,"sku":"lymphoma-leukemia-trial-1","brand":false,"position":4,"category":"Medicines\/| Clinical Trials"},{"id":"459","name":"Evaluation of Parsaclisib plus Ruxolitinib in patients with Myelofibrosis who have not responded to Ruxolitinib alone","price":1,"sku":"myelofibrosis-trial-1","brand":false,"position":5,"category":"Medicines\/| Clinical Trials"},{"id":"458","name":"Evaluation of Nivolumab plus Docetaxel in men with Prostate Cancer","price":1,"sku":"prostate-cancer-trial-1","brand":false,"position":6,"category":"Medicines\/| Clinical Trials"}]

| خيارات الوصول للتجارب السريرية

  1. تقييم Nivolumab بالإضافة إلى Docetaxel في الرجال المصابين بسرطان البروستاتا
    Evaluation of Nivolumab plus Docetaxel in men with Prostate Cancer
    سرطان البروستاتا
    السعر متاح عند الطلب
عرض قائمةشبكة List

6 عناصر

تعيين الاتجاه التنازلي
لنا 0